| Dr David Brett Sable, MD, PHD | |
|
5210 Webb Rd, Tampa, FL 33615-4518 | |
| (813) 882-9986 | |
| (813) 882-9849 |
| Full Name | Dr David Brett Sable |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 28 Years |
| Location | 5210 Webb Rd, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245216092 | NPI | - | NPPES |
| 002193300 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Josephs Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Academic Alliance In Dermatology Inc | 8729077938 | 26 |
News Archive
FUJIFILM Medical Systems U.S.A. today announced the commercial availability of version 6.0, the latest version of the company's Synapse RIS and Synapse TeleRIS applications.
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.
High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
› Verified 9 days ago
| Entity Name | Academic Alliance In Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538119722 PECOS PAC ID: 8729077938 Enrollment ID: O20040511001288 |
News Archive
FUJIFILM Medical Systems U.S.A. today announced the commercial availability of version 6.0, the latest version of the company's Synapse RIS and Synapse TeleRIS applications.
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.
High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Brett Sable, MD, PHD 4201 Bayshore Blvd, #1502, Tampa, FL 33611-1669 Ph: (813) 545-1585 | Dr David Brett Sable, MD, PHD 5210 Webb Rd, Tampa, FL 33615-4518 Ph: (813) 882-9986 |
News Archive
FUJIFILM Medical Systems U.S.A. today announced the commercial availability of version 6.0, the latest version of the company's Synapse RIS and Synapse TeleRIS applications.
Molecular dermatology research and development innovator HairDX today announced the results of a six month pilot study that presents, for the first time, evidence that genetic mechanisms may predict treatment response to Finasteride for postmenopausal female Androgenetic Alopecia (female hair loss).
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.
High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
› Verified 9 days ago
Dr. Scott Forrester Lindsey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 310 S. Macdill Ave., Suite 201, Tampa, FL 33609 Phone: 813-609-3810 Fax: 813-559-1846 | |
Dr. Alan M Freedman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4412 W Osborne Ave, Tampa, FL 33614 Phone: 813-914-9100 Fax: 239-278-1159 | |
Philip Shenefelt, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 12901 Bruce B Downs Blvd, Mdc 79, Tampa, FL 33612 Phone: 813-974-2920 | |
Dr. Henry E Wiley Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1425 S Howard Ave, Tampa, FL 33606 Phone: 813-253-2635 Fax: 813-254-7142 | |
Ferwa Mohammed, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1208 E Kennedy Blvd Ste 221, Tampa, FL 33602 Phone: 813-590-6868 | |
Dr. Salma Z Pothiawala, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15310 Amberly Dr, Suite 150, Tampa, FL 33647 Phone: 813-978-8888 Fax: 813-972-8974 | |
Brianna Castillo, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 11601 Sheldon Rd, Tampa, FL 33626 Phone: 813-324-6630 Fax: 813-926-1500 |